Effect of the 1-hour Sepsis Bundle on In-hospital Mortality in Patients With Sepsis in the Emergency Department
1BED
2 other identifiers
interventional
873
1 country
1
Brief Summary
Reducing the mortality and morbidity of sepsis is a worldwide priority for almost 20 years. Since an observational study in the NY state, which reported in-hospital mortality increased, associated with each supplemental hour to complete the sepsis bundle, SSC guidelines have decided in 2018 to recommend a short timeframe of 1-h to complete the sepsis bundle. This new recommendation is vividly debated due to a lack of evidences of its relevance. No trial has ever studied a sepsis intervention when applied as early as Emergency Department ED triage (newly recommended 1-h sepsis bundle consider time zero as time of ED triage). The aim of this trial is to demonstrate that the early implementation at ED triage of the 1-hour bundle by ED physicians improves in-hospital mortality in patients with sepsis, and therefore provides the required robust evidence for the SSC guidance to enhance physicians and stakeholder adherence. This is a superiority, international multicenter, open trial with a stepped wedge randomisation. All centers will recruit adult emergency patients with suspicion of sepsis as defined by a suspicion of infection and suspicion of life threatening organ dysfunction (quick SOFA or SOFA ≥ 2, hypotension or hyperlactatemia). According to the center period, the management of sepsis patients will be based either following the current recommended 1-hour sepsis bundle (intervention group) or at the discretion of the treating ED physician as in current routine practice (control group). There is no intervention that is "added" by the research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable sepsis
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2022
CompletedFirst Posted
Study publicly available on registry
March 10, 2022
CompletedStudy Start
First participant enrolled
June 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 13, 2023
CompletedFebruary 26, 2024
February 1, 2024
1.3 years
February 9, 2022
February 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
In-hospital mortality
Safety Issue ? : Yes / No
truncated at day 28
Secondary Outcomes (7)
Amount of fluid resuscitation
in the first 24 hours
Acute heart failure
During the first 24 hours
SOFA score
Up to 3 days
ICU length of stay
Up to 3 days
Total number of days under mechanical ventilation, renal replacement therapy, and vasopressor-free
within 28 days
- +2 more secondary outcomes
Study Arms (2)
1-h sepsis bundle
EXPERIMENTALCurrent practice
NO INTERVENTIONInterventions
The sepsis management will be delivered in a timely manner within 60 minutes of ED triage including * usual test and treatment * blood culture * lactate measurement * broad spectrum antibiotics * In case of hypotension or lactate \> 4, rapid administration of 30ml/kg crystalloid fluid resuscitation will be mandated * In case of initial elevated lactate (\> 2 mmol/l), a second lactate measurement should be done after initial fluid resuscitation.
Eligibility Criteria
You may qualify if:
- ED adult patients, with suspected infection
- AND at least one of the following:
- Serum lactate \> 2.0 mmol/l
- Systolic blood pressure \< 90 mmHg
- Suspicion of sepsis as defined by the SEPSIS-3 International consensus: life threatening organ dysfunction identified by a SOFA score of 2 at least or a quick SOFA score of 2 at least (altered consciousness, systolic blood pressure \< 100 mmHg, respiratory rate \> 22)
You may not qualify if:
- Patient living in assisted-living home or nursing home or palliative center
- Patient under legal protection measure (tutorship or curatorship) and patient deprived of freedom
- Anticipated life expectancy \< 3 months or "do not resuscitate" order
- Known acute heart failure
- No social security
- Pregnancy and breastfeeding
- Prisoners
- Participation in another interventional trial (RIPH 1 et 2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency department Hospital Pitié-Salpêtrière
Paris, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yonathan FREUND, PU-PH
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2022
First Posted
March 10, 2022
Study Start
June 13, 2022
Primary Completion
October 13, 2023
Study Completion
October 13, 2023
Last Updated
February 26, 2024
Record last verified: 2024-02